BSKB’s intellectual property attorneys write articles on important and timely topics in intellectual property law across a variety of industries. You’ll find the latest articles and industry insights here.
April 29, 2022
Patent Law Institute
BSKB’s Chad Rink recently co-lectured with Briana Barron during the 2022 Patent Law Institute (PLI) virtual meeting. Their topic was “Responding to Examiner Rejections in Chem/Pharma/Bio Applications.” Chad and Briana discussed recent court decisions covering written description, obviousness, and inequitable conduct.
April 26, 2022
The effects of the ‘skinny label’ decision are being felt across pharma. MaryAnne Armstrong of Birch, Stewart, Kolasch & Birch revisits GSK v Teva.
April 13, 2022
Bloomberg Law Podcast
In this week's Bloomberg Law Podcast, BSKB’s Leonard Svensson is featured discussing how “Impossible Foods is testing a tastes-like-meat patent in court.”
January 5, 2022
Patent applications: Kite raises the game
Hailey Bureau, Ph.D. (Associate) and Olayinka Oladele (Law Clerk from Texas Southern University's Thurgood Marshall School of Law) recently co-authored and article for WIPR regarding the Federal Circuit's recent "added complexities to the drafting of patent applications for antibody inventions" as a result of the cases Amgen v Sanofi (2021) and Juno Therapeutics v Kite Pharma (2021).
September 30, 2021
Eugene Perez weighs in on the “Restoring America Invents Act”, proposed by Senators Leahy (D-VT) and Cornyn (R-TX), in an article from IPWatchdog, Inc
September 27, 2021
WIPR Patents Live
WIPR Patents Live hosted BSKB Attorneys David Bilodeau (Partner) and Brad Fritz (Associate) in a Q&A with Tom Phillips regarding Rain Computing v. Samsung.
September 16, 2021
MaryAnne Armstrong, PhD, offers her perspective on the "impact of the America Invents Act" during the bill's 10 year anniversary in an article from IPWatchdog, Inc.
July 7, 2021
MaryAnne Armstrong discusses whether the same tests for non-obviousness of biotech patents will be applied to pharma inventions developed using AI.
June 22, 2021
Partner, Eugene T. Perez was recently quoted in an article by IPWatchdog regarding this week's U.S. Supreme Court patent decision in United States v. Arthrex, Inc. Et Al.
June 17, 2021
MaryAnne Armstrong, Ph. D., sits down with LSIPR to discuss artificial intelligence's impact on IP industry relating to life sciences and pharmaceuticals.
April 16, 2021
Birch, Stewart, Kolasch & Birch, LLP
Substitute/Cultivated Meat Technology: A Deep-Dive Patent Landscape Analysis by Leonard R. Svensson, Esq.
March 26, 2021
December 1, 2020
Birch, Stewart, Kolasch & Birch, LLP is pleased to announce that David A. Bilodeau has been included in this Edition of The Best Lawyers in America.
November 22, 2020
Printed publications: an evolving doctrine
While the PTAB’s decision in Hulu provides some guidance for post-grant proceedings, there is still no bright-line rule as to what constitutes a “printed publication”. Eugene Perez of Birch Stewart Kolasch Birch examines current case rulings.
November 1, 2020
BSKB ASSISTS CLIENT IN SUCCESSFUL IPR CHALLENGES TO BIOPHARMACEUTICAL PATENTS FOR TREATING POMPE DISEASE
BSKB assists client in successful IPR Challenges to Biopharmaceutical Patents for Treating Pompe Disease
July 24, 2020
In surveys throughout the Washington, D.C. metro area, three possible replacement names have emerged as favorites among the fans: Warriors, Red Wolves, and Redtails. Armed with the knowledge of the name change and the relative popularity of the possible replacement names, two enterprising individuals have applied to obtain a federal trademark registration for the marks WARRIORS, WASHINGTON RED WOLVES, and WASHINGTON REDTAILS, respectively. Neither applicant appears to be connected to the owners of the Washington D.C. professional football team.
July 10, 2020
MaryAnne Armstrong, Ph.D. discusses the potential risks to IP rights with open-access to technology, medicines and devices in the fight against COVID-19 in the latest issue of LSIPR.
April 28, 2020
World Intellectual Property Review
Chad Rink and Hailey Bureau, Ph.D. talk about indefinite claims at the PTAB and alternative routes in WIPR- Issue 1.
February 12, 2020
Six mutants of the tryptophan zipper peptide trpzip1 have been computationally and experimentally characterized. We determine the varying roles in secondary structure stability of specific residues through a mutation assay. Four of the mutations directly effect the Trp–Trp interactions and two of the mutations target the salt bridge between Glu5 and Lys8. CD spectra and thermal unfolding are used to determine the secondary structure and stability of the mutants compared to the wildtype peptide. Adaptive steered molecular dynamics has been used to obtain the energetics of the unfolding pathways of the mutations. The hydrogen bonding patterns and side-chain interactions over the course of unfolding have also been calculated and compared to wildtype trpzip1. The key finding from this work is the importance of a stabilizing non-native salt bridge pair present in the K8L mutation.
May 20, 2019
Life Science IP Review
John Heithaus and Gerald Murphy discuss the evolution of antibody written description standards at the USPTO. Read more of their article featured in Life Science IP Review.